Carerx Stock Five Year Return
CHHHF Stock | USD 1.41 0.12 7.84% |
CareRx fundamentals help investors to digest information that contributes to CareRx's financial success or failures. It also enables traders to predict the movement of CareRx Pink Sheet. The fundamental analysis module provides a way to measure CareRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx pink sheet.
CareRx |
CareRx Company Five Year Return Analysis
CareRx's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, CareRx has a Five Year Return of 0.0%. This indicator is about the same for the Food & Staples Retailing average (which is currently at 0.0) sector and about the same as Consumer Staples (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
All Next | Launch Module |
CareRx Fundamentals
Return On Equity | -0.49 | |||
Return On Asset | 0.0204 | |||
Profit Margin | (0.09) % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 170.84 M | |||
Shares Outstanding | 51.96 M | |||
Shares Owned By Insiders | 30.25 % | |||
Shares Owned By Institutions | 32.82 % | |||
Price To Earning | 13.57 X | |||
Price To Book | 1.78 X | |||
Price To Sales | 0.22 X | |||
Revenue | 262.63 M | |||
Gross Profit | 75.28 M | |||
EBITDA | 6.15 M | |||
Net Income | (22.73 M) | |||
Cash And Equivalents | 15.2 M | |||
Cash Per Share | 0.32 X | |||
Total Debt | 106.11 M | |||
Debt To Equity | 2.35 % | |||
Current Ratio | 1.69 X | |||
Book Value Per Share | 1.24 X | |||
Cash Flow From Operations | 7.27 M | |||
Earnings Per Share | (0.38) X | |||
Number Of Employees | 1.38 K | |||
Beta | 0.79 | |||
Market Capitalization | 101.85 M | |||
Total Asset | 282.82 M | |||
Net Asset | 282.82 M |
About CareRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in CareRx Pink Sheet
CareRx financial ratios help investors to determine whether CareRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx security.